ALYX CAPRI: Open Payments
NPI 1477335677 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $265 · 2025 $700
Food & beverage: $677Education: $24
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $150 |
| ABBVIE INC. | 4 | $113 |
| LEO Pharma Inc. | 4 | $108 |
| Journey Medical Corporation | 3 | $65 |
| KYOWA KIRIN, INC. | 2 | $52 |
| Almirall LLC | 2 | $43 |
| GENZYME CORPORATION | 1 | $39 |
| Incyte Corporation | 2 | $36 |
| Galderma Laboratories, L.P. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
Products named: TREMFYA, SKYRIZI, ADBRY, DUPIXENT, POTELIGEO, Seysara, OPZELURA, NEMLUVIO.
Industry payments across CO — which companies pay providers there.
